Literature DB >> 12913262

Glucurono- and sulfo-conjugation of kaempferol in rat liver subcellular preparations and cultured hepatocytes.

Shinya Yodogawa1, Takayuki Arakawa, Narumi Sugihara, Koji Furuno.   

Abstract

Glucurono- and sulfo-conjugation of kaempferol in rat liver preparations and cultured hepatocytes were studied using high-performance liquid chromatography (HPLC) with two distinctly different elution solvents. Kaempferol glucuronides and sulfates were produced by treating kaempferol with microsomes plus UDPGA or with cytosol plus PAPS, respectively. HPLC analysis of the conjugates revealed one major and three minor glucuronides with solvent A and one sulfate with solvent B. Kaempferol metabolites produced by cultured hepatocytes also consisted of four glucuronides and one minor sulfate, all of which corresponded to their respective in vitro-produced conjugates in the liver subcellular preparations. The relative proportion of kaempferol sulfate accounted for about 9% of the total conjugates in the cultured hepatocytes. The kinetic data on glucurono- and sulfo-conjugation of kaempferol by the liver subcellular preparations correlated well with the preferential production of kaempferol glucuronides in the cultured hepatocytes. Glucurono- and sulfo-conjugation of 3-, 5- and 7-OH flavones in the liver subcellular preparations were also kinetically characterized. 7-OH flavone was predominantly conjugated to form a glucuronide compared to 3- and 5-OH flavones. These data suggest that glucuronidation at the 7-OH position on the A-ring is a major metabolic pathway of kaempferol in hepatic cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12913262     DOI: 10.1248/bpb.26.1120

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  6 in total

1.  Simultaneous determination by UPLC-MS/MS of seven bioactive compounds in rat plasma after oral administration of Ginkgo biloba tablets: application to a pharmacokinetic study.

Authors:  Wen-ping Wang; Na Liu; Qian Kang; Pei-pei Du; Yi Lan; Bo-chen Zhao; Yan-yan Chen; Qing Zhang; Hui Li; Ye-wen Zhang; Qing Wu
Journal:  J Zhejiang Univ Sci B       Date:  2014-11       Impact factor: 3.066

2.  In Vivo Exposure of Kaempferol Is Driven by Phase II Metabolic Enzymes and Efflux Transporters.

Authors:  Liang Zheng; Lijun Zhu; Min Zhao; Jian Shi; Yuhuan Li; Jia Yu; Huangyu Jiang; Jinjun Wu; Yunli Tong; Yuting Liu; Ming Hu; Linlin Lu; Zhongqiu Liu
Journal:  AAPS J       Date:  2016-07-08       Impact factor: 4.009

Review 3.  The analgesic potential of glycosides derived from medicinal plants.

Authors:  Haroon Khan; Aini Pervaiz; Sebastiano Intagliata; Niranjan Das; Kalyan C Nagulapalli Venkata; Atanas G Atanasov; Agnieszka Najda; Seyed Mohammad Nabavi; Dongdong Wang; Valeria Pittalà; Anupam Bishayee
Journal:  Daru       Date:  2020-02-14       Impact factor: 3.117

4.  Platelet-mediated metabolism of the common dietary flavonoid, quercetin.

Authors:  Bernice Wright; Trevor Gibson; Jeremy Spencer; Julie A Lovegrove; Jonathan M Gibbins
Journal:  PLoS One       Date:  2010-03-12       Impact factor: 3.240

5.  Metabolism, oral bioavailability and pharmacokinetics of chemopreventive kaempferol in rats.

Authors:  Avantika Barve; Chi Chen; Vidya Hebbar; Joseph Desiderio; Constance Lay-Lay Saw; Ah-Ng Kong
Journal:  Biopharm Drug Dispos       Date:  2009-10       Impact factor: 1.627

6.  Pharmacological Targets of Kaempferol Within Inflammatory Pathways-A Hint Towards the Central Role of Tryptophan Metabolism.

Authors:  Stefanie Hofer; Simon Geisler; Rebecca Lisandrelli; Hieu Nguyen Ngoc; Markus Ganzera; Harald Schennach; Dietmar Fuchs; Julian E Fuchs; Johanna M Gostner; Katharina Kurz
Journal:  Antioxidants (Basel)       Date:  2020-02-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.